CH / EN
About Kingfriend
Kingfriend Overview

Nanjing Kingfriend integrates drug research and development, production and sales.

Listed on SSE A share on 19th July, 2017, Kingfriend has, not only the world’s leading isolator production line and advanced aseptic injection production technology, but also a globalized quality system, approved by many countries and regions, including China, the United States, Europe, Japan and Brazil, etc. With a world-class production research and development speed and the globalized quality awareness, we have the sales capability that make us take root in the U.S. market. Besides, injectable CDMO service, covering the global market while targeting at China and US markets’, can be provided by us. By attracting and recruiting talents from all over the globe, our newly established bio-innovative pharmaceuticals business department aims at becoming an innovative and international biopharmaceutical company that is superior in pharmaceutical field.
  • 50+
  • 10+
  • 3times
  • 10+
  • 10+
Total ANDA approvals
New ANDA approvals obtained each year
FDA-compliant high-speed isolator production line
Annual declaration of products to FDA
Cumulative number of FDA inspection passed
The Global Industry Layout

We establish efficient, integrated and open project management systems for global pharmaceutical companies

  • Nanjing Headquarter

    R&D Center
    Development, production and commercial manufacturing of small molecule injectables
    Drug development and commercialization based on mRNA technology
    Treatment based on nucleic acid detection technology (mRNA)
    Bioinformatics determination of target molecules
    platform for mRNA in vitro synthesis and modification
    Drug delivery system development

  • Cheng Du

    R&D center
    Hydro-acupuncture and lyophilization product line
    Monoclonal antibody-based drugs (mAb)
    Early research and development of monoclonal antibody
    Commercial development monoclonal antibodies

  • Chicago, USA

    Global Clinical Research Center
    U.S. Marketing
Milestones

Over the past 30 years, we have been refreshing our goals and making positive progress.

2022
57 ANDA approvals obtained in total
pipeline expansion at a rate of 10 new projects per year
2021
Establishment of Bio-innovative Business Department
Improved R&D capabilities and entered the field of biologics
2019
Acquisition of US pharmaceutical company Meitheal
Broadened the global market of preparations and completed the coverage of the industry chain
2016
Acquisition of Chengdu Jianjin Pharmaceutical
Full set of FDA-compliant GMP workshop
audited by the FDA
2014
Passed CFDA GMP inspection
Obtained three domestic approvals and started filling with ANDA
2011
Construction of Nanjing FDF plant started
The world’s top FDF plant
2004
Launch of enoxaparin, nadroparin and dalteparin preparation projects
Initiated the development and declaration of heparin-based APIs and preparations
2000
Establishment of Nanjing Kingfriend Biochemical Pharmaceutical Co, Ltd
Ventured into pharmaceutical export business
1991
Establishment of Nanjing Kingfriend Chemical Biopharmaceutical Factory
Rapid development in heparin industry
1987
Involvement in the field of heparin sodium
Pioneer in the heparin industry in China
2022
2021
2019
2016
2014
2011
2004
2000
1991
1987
Enterprise Honors

Our employees, who are enterprising and innovative, have obtained a number of remarkable achievements.

  • Awarded the title of Nanjing Outstanding Private Enterprise and Entrepreneur
    2018
    Awarded the title of Nanjing Outstanding Private Enterprise and Entrepreneur
  • Nanjing Municipal Key Leading Enterprise of Agricultural Industrialization
    2022
    Nanjing Municipal Key Leading Enterprise of Agricultural Industrialization
  • Outstanding Company of Open Economy of Jiangsu Province
    2012
    Outstanding Company of Open Economy of Jiangsu Province
  • Enterprise Technology Center recognized by Jiangsu Province
    2022
    Enterprise Technology Center recognized by Jiangsu Province
  • Enterprise Technology Center recognized by Jiangsu Province
    2014
    Enterprise Technology Center recognized by Jiangsu Province
  • National-level High-tech Enterprise Certificate
    2018
    National-level High-tech Enterprise Certificate
  • Awarded the title of Nanjing Smart Factory
    2015
    Awarded the title of Nanjing Smart Factory
  • Private Technology Enterprise Certificate
    2017
    Private Technology Enterprise Certificate
More honors
Principles of Kingfriend

Principles of Kingfriend

Our four main principles reflect the quality standard of our products and guide our decisions and actions.
Learn more Principles of Kingfriend
Career Development

Career Development

Our principles aim at improving employee’s competency and happiness and fulfilling their needs and sense of achievement.
Learn more Career Development
Stock price
12.820
-0.02
©2024 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd苏ICP备13012010号
XML 地图